Mapping the Glucuronidome
绘制葡萄糖醛酸糖苷酸组图
基本信息
- 批准号:10605902
- 负责人:
- 金额:$ 3.57万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2023
- 资助国家:美国
- 起止时间:2023-07-01 至 2025-06-30
- 项目状态:未结题
- 来源:
- 关键词:AffectAntibiotic TherapyAntibioticsAryl Hydrocarbon ReceptorBeta-glucuronidaseBile AcidsBiologicalBiological AssayBloodBlood specimenC57BL/6N MouseCarcinogensChemicalsChronic DiseaseChronologyColonColon CarcinomaComplex MixturesCytochrome P450DataDatabasesDevelopmentDiagnosisDietDigestionDiseaseDrug Metabolic DetoxicationDrug PrescriptionsEnterohepatic CirculationEnzymesEpitheliumExcisionFatty AcidsFecesFrequenciesGene ExpressionGenesGenomicsGerm-FreeGlucuronic AcidsGlucuronidesGlucuronosyltransferaseGoalsHealthHormonesInflammationInflammatoryInflammatory Bowel DiseasesInfluentialsIntestinal permeabilityIntestinesKnowledgeLigandsLiverLong-Term EffectsMalignant NeoplasmsMapsMass Spectrum AnalysisMeasuresMetabolicMetabolismMetagenomicsMethodsMicrobeMolecularMolecular Biology TechniquesNatural regenerationNon-Insulin-Dependent Diabetes MellitusNon-Steroidal Anti-Inflammatory AgentsNutrientObesityOutcomePathway interactionsPeroxisome Proliferator-Activated ReceptorsPharmaceutical PreparationsPharmacologic SubstancePhasePhysiologicalPreventionProcessQualifyingRegulator GenesResearchResearch ProposalsRisk FactorsRoleSamplingSignal TransductionStressStructureTaxonomyTechniquesToxic effectTrainingTreatment EfficacyUlcerUnited StatesUrineVitaminsXenobiotic MetabolismXenobioticsabsorptionadverse drug reactionchemical additionchemotherapyconstitutive androstane receptordietarydrug metabolismexperimental studygut microbiomehost microbiomeimprovedin vivoindividualized medicineinsightmetabolomicsmetagenomic sequencingmicrobialmicrobial communitymicrobiomemicrobiome analysismultiple omicsnovelpregnane X receptorpublic databasereceptorreconstitutionsample collectionside effectskillsstool sampletargeted treatmenttoxicanttranscription factorurinarywater solubility
项目摘要
Project Summary
Mapping the Glucuronidome. One of the most important mammalian detoxification (inactivation) methods is the
chemical addition of glucuronic acid to biologically active compounds, glucuronidation. The rate of
glucuronidation is altered by dietary compounds and the successful elimination of glucuronidated chemicals is
inhibited by microbial removal of the glucuronic acid moiety, regenerating the active, and often toxic, compound.
Changes in the pool of glucuronides have important implications for the prevention, diagnosis, and treatment of
chronic diseases. Recent research efforts have focused on the role of microbiome manipulation on drug
metabolism, specifically the inhibition of microbial β-glucuronidase enzymes for reducing adverse drug reactions
to NSAIDs and chemotherapies and improving pharmaceutical treatment efficacy. Comprehensive research of
the physiologic implications of host-metabolite-microbe interactions is possible due to recent advances in mass
spectrometry methods for identifying and quantifying metabolites in complex mixtures (blood, urine, and feces)
and high-throughput -omics techniques for functional analysis of the microbiome. This proposed research aims
to develop an integrative multi-omics pipeline incorporating novel metabolomic methods, metagenomic
sequencing, and molecular biology techniques to define the physiologic effects of host-glucuronide-microbiome
interactions. The training will provide for a collaborative effort between xenobiotic metabolism, mass
spectrometry, and microbiome experts to experimentally disrupt glucuronidation, map glucuronide exchange
dynamics, and quantify resultant host metabolic signaling. The research will provide for the development of a
much needed, first-of-its-kind, comprehensive, and publicly available database of glucuronidation, facilitating the
incorporation of powerful metabolomics methods to research advancing the understanding of xenobiotic
metabolism. The proposed research will inform the current understanding of host-microbiome interaction effects
on xenobiotic metabolism and host health, with important implications for the development of individualized
medicine and microbe-targeted therapies.
项目概要
绘制葡萄糖醛酸组图是最重要的哺乳动物解毒(灭活)方法之一。
葡萄糖醛酸与生物活性化合物的化学加成,葡萄糖醛酸化的速率。
膳食化合物会改变葡萄糖醛酸化,成功消除葡萄糖醛酸化化学物质是
通过微生物去除葡萄糖醛酸部分来抑制,从而再生活性且通常有毒的化合物。
葡萄糖醛酸苷库的变化对于以下疾病的预防、诊断和治疗具有重要意义:
最近的研究工作集中在微生物组操纵对药物的作用。
代谢,特别是抑制微生物 β-葡萄糖醛酸酶,以减少药物不良反应
对NSAIDs和化疗以及提高药物治疗疗效的综合研究。
由于质量的最新进展,宿主-代谢物-微生物相互作用的生理影响是可能的
用于识别和量化复杂混合物(血液、尿液和粪便)中代谢物的光谱测定方法
和用于微生物组功能分析的高通量组学技术本提议的研究目标。
开发综合多组学管道,结合新颖的代谢组学方法、宏基因组学
测序和分子生物学技术来定义宿主-葡萄糖苷酸-微生物组的生理效应
该培训将提供外源代谢、质量之间的协作。
光谱测定法和微生物组专家通过实验破坏葡萄糖醛酸化,绘制葡萄糖醛酸交换图
动力学,并量化由此产生的宿主代谢信号。该研究将为开发一种新的方法提供依据。
急需的、首创的、全面的、公开的葡萄糖醛酸化数据库,促进
结合强大的代谢组学方法进行研究,增进对异生素的理解
拟议的研究将为当前对宿主-微生物组相互作用影响的理解提供信息。
外源代谢和宿主健康,对个体化的发展具有重要意义
医学和微生物靶向治疗。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Nina Boyle其他文献
Nina Boyle的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
相似国自然基金
基于“成分-肠道菌群-胆汁酸轴”研究生姜-干姜走守并用治疗抗生素相关性腹泻配伍机理
- 批准号:82374053
- 批准年份:2023
- 资助金额:48 万元
- 项目类别:面上项目
抗生素治疗压力下养殖场废弃物中抗生素抗性基因水平转移机制研究
- 批准号:
- 批准年份:2022
- 资助金额:30 万元
- 项目类别:青年科学基金项目
抗生素治疗药物监测及耐药症候一体化阵列传感技术研究
- 批准号:
- 批准年份:2022
- 资助金额:30 万元
- 项目类别:青年科学基金项目
具有内源抗炎活性的聚乙二醇化氨基糖苷类抗生素在脓毒症治疗中的应用研究
- 批准号:
- 批准年份:2021
- 资助金额:30 万元
- 项目类别:青年科学基金项目
具有内源抗炎活性的聚乙二醇化氨基糖苷类抗生素在脓毒症治疗中的应用研究
- 批准号:32101073
- 批准年份:2021
- 资助金额:30 万元
- 项目类别:青年科学基金项目
相似海外基金
A Novel Sublingual Vaccine to Prevent Neisseria Gonorrhoeae Infection
预防淋病奈瑟菌感染的新型舌下疫苗
- 批准号:
10699065 - 财政年份:2023
- 资助金额:
$ 3.57万 - 项目类别:
Interactions Between the Microbiota and Helicobacter pylori in Gastric Carcinogenesis
微生物群与幽门螺杆菌在胃癌发生中的相互作用
- 批准号:
10709135 - 财政年份:2023
- 资助金额:
$ 3.57万 - 项目类别:
A Randomized Pilot and Feasibility Study of a cultuRE-Directed approach to Urinary traCT Infection symptoms in older womeN: a mixed methods evaluation - the REDUCTION trial
针对老年女性尿路感染症状的文化导向方法的随机试验和可行性研究:混合方法评估 - REDUCTION 试验
- 批准号:
10586250 - 财政年份:2023
- 资助金额:
$ 3.57万 - 项目类别:
The role of the gut microbiome in ICB-induced anti-tumor response and toxicity
肠道微生物组在 ICB 诱导的抗肿瘤反应和毒性中的作用
- 批准号:
10606715 - 财政年份:2023
- 资助金额:
$ 3.57万 - 项目类别:
Molecular Mechanisms of Pseudomonas aeruginosa Antibiotic Persistence in Monocultures and Microbial Communities
单一栽培和微生物群落中铜绿假单胞菌抗生素持久性的分子机制
- 批准号:
10749974 - 财政年份:2023
- 资助金额:
$ 3.57万 - 项目类别: